Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...

Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

The increasing popularity of these weight loss drugs is likely to shape how individuals approach food choices and meal ...

This week, a letter surfaced in which Eli Lilly asked for a patient to release medical information so it could contact her ...

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary ...